EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MODERN OPTIMAL DRUG THERAPY OF STABLE ANGINA

Vasyl Skybchyk, Oksana Turba, Orysya Kysil

Acta Medica Leopoliensia · 22.12.2025 · 31 (3-4) · 110-127

DOI: 10.25040/aml2025.3-4.110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Medica Leopoliensia, online erschienen am 22.12.2025. Verfasst von Vasyl Skybchyk und 2 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To reveal current approaches to the treatment of stable angina using optimal drug therapy (ODT) simultaneously highlighting new treatment modalities and the growing clinical significance of coronary microvascular dysfunction (CMD). Material and Methods. Methods used: bibliographic, analytical, systemic approach. Object of research: international European (2024) and American recommendations (2023), current foreign sources on optimal drug therapy for stable angina. Subject of research: modern medicines treatment methods for stable angina. Results and Discussion. Despite its proven effectiveness, ODT remains an underutilized tool in actual clinical practice. Analysis of data from large registries and clinical trials reveals significant problems in prescribtion and titration antianginal medications. This review synthesizes the results of existing studies and key clinical trials to outline both established and novel approaches to the treatment of chronic stable angina. Beta-blockers and calcium channel blockers remain the basis of symptomatic treatment, while nitrates, ranolazine, ivabradine, and trimetazidine may be considered for refractory symptoms. Few new pharmacological treatments have emerged in recent decades, highlighting the critical need for innovation, particularly in the treatment of CMD, which is increasingly defined by a distinct pathophysiological entity requiring targeted therapy.

Conclusions

Modern management of patients with stable angina requires the shift from a traditional hierarchical approach to an individualized, patient-centered strategy. ODT should be flexible, taking into account comorbidities, treatment tolerability, and, most importantly, the patient's personal preferences. Beta-blockers and calcium channel blockers remain the mainstay of therapy, while adjuvant medications such as ranolazine, ivabradine, and nicorandil play an important role in specific clinical situations.

Zitieren

APA

Skybchyk, V., Turba, O., & Kysil, O. (2025). MODERN OPTIMAL DRUG THERAPY OF STABLE ANGINA. Acta Medica Leopoliensia, 31(3-4), 110-127. https://doi.org/10.25040/aml2025.3-4.110

Vancouver

Skybchyk V, Turba O, Kysil O. MODERN OPTIMAL DRUG THERAPY OF STABLE ANGINA. Acta Medica Leopoliensia. 2025;31(3-4):110-127. doi:10.25040/aml2025.3-4.110

BibTeX
@article{Skybchyk2025,
  author = {Skybchyk, Vasyl and Turba, Oksana and Kysil, Orysya},
  title = {MODERN OPTIMAL DRUG THERAPY OF STABLE ANGINA},
  journal = {Acta Medica Leopoliensia},
  year = {2025},
  volume = {31},
  number = {3-4},
  pages = {110--127},
  doi = {10.25040/aml2025.3-4.110}
}
Kostenlos starten →